肠道微生物菌群对脑及行为的影响

肠道微生物菌群组成的变化对正常生理的影响及其在疾病中的作用逐渐成为研究热点。肠道微生物菌群通过脑肠轴影响宿主生理学的各个方面,包括脑-肠交流、脑功能甚至行为。对无菌动物、被致病细菌感染的、使用益生菌或用抗生素药物的动物研究表明,肠道微生物菌群可以调节宿主焦虑样症状及行为。研究表明对肠道微生物菌群的调节可能是治疗复杂中枢神经系统失调症的新策略。     

COPD的下呼吸道微生态研究进展

新一代测序技术的发展,拓展了人类对肺微生物组的认识,下呼吸道微生物组与呼吸系统疾病的关系日益受到关注。下呼吸道微生物组包含平衡的共生菌群和致病菌群,在慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)中,其疾病的严重性、炎症程度或抗生素等治疗因素均会影响肺部微生物群稳态,下呼吸道微生物群落的改变又可能通过操纵炎症或免疫过程,对COPD的病程产生影响。据此,本文通过回顾近年来对COPD下呼吸道微生态的研究,总结了COPD患者的下呼吸道微生态特征及菌群定植情况,探讨下呼吸道微生态与COPD发病机制之间的相关性和治疗对策,希望为COPD的诊断和治疗提供新思路。     

阴道微生物组：种群特征与疾病干预治疗

高通量测序技术的发展显著加快了对人类微生物组的理解。将人体微生物组与疾病关联,力求阐明疾病的发生进程,是推进个性化精准医疗的重要研究方向。近年来,栖居于女性阴道的微生物菌群日益受到关注,发现其生态失调与疾病发生、演变密不可分。文中综述了阴道微生物组与生殖道疾病发生、进展和治疗的最新进展,同时对阴道微生物组培养组、益生菌工程化改造以及合成菌群在阴道微生物组学研究以及疾病干预与治疗方面的前景进行了展望。     

肠道微生物与认知功能

近年来大量研究表明肠道微生物的改变与认知行为之间存在明显的相关性。通过无菌动物、细菌感染以及益生菌或抗生素干预等方式改变宿主的肠道菌群,可以调节宿主的认知行为,包括学习和记忆能力。应激和饮食结构的变化也会改变宿主的肠道微生物,进而影响宿主行为。同时在胃肠道疾病和某些非肠道疾病状态下也会伴随着宿主认知行为的改变。本研究将重点讨论在人类和动物研究中发现的肠道微生物多样性的改变如何影响大脑功能和认知行为。     

加强圈养野生动物疫病防控技术研究

2005年,我们进行了部分动物园饲养野生动物使用疫苗情况调查,了解到动物园动物使用36种疫苗预防31种疫病,其中涉及人兽共患病9种,7种疫病是动物园动物没有明确发生但在进行免疫预防的疾病。调查发现所用疫苗没有适应野生动物使用的疫苗和相应的免疫程序,疫苗接种均是参照家畜家禽的使用剂量和程序,大部分动物园动物没有进行禽流感、狂犬病等人兽共患病的监测,动物园之间的技术交流较少。主要原因是技术落后、设备缺乏、人员不济。应加强对圈养野生动物疾病防控技术的研究,加强对动物园动物重要疫病的监测,进一步加强动物园之间对疫病信息的交流和防疫资源的利用,加大对动物园动物疫病的研究投入。     

肠道微生物与过敏性疾病关系研究进展

目前,过敏性疾病的防治主要依赖于使用抗生素,然而抗生素的滥用已造成了严重的危害。近年来随着肠道微生物相关研究的不断深入以及人们对过敏性疾病的日益关注与重视,肠道微生物与过敏性疾病间的关系逐渐受到科学家们的关注。调整肠道菌群结构可能为过敏性疾病的防治提供新的思路。目前对肠道微生物与过敏性疾病间的相关性报道相对较少且未有深层次的剖析。本文总结了关于肠道微生物与过敏性疾病关系的研究起源、发展与现状,旨在为过敏性疾病的防治提供新策略。     

无菌动物及其在微生物与宿主互作机制研究中的应用

无菌动物是指通过现代技术手段在其体内外的任何部位均检测不出细菌、真菌、放线菌、支原体、衣原体、螺旋体、立克次氏体、病毒、原生动物和寄生虫的动物。无菌动物因其不携带任何微生物,可转化为携带特定微生物的动物,同时因其免疫系统处于休眠状态,对微生物感染异常敏感,可建立多种悉生动物模型,用于特定微生物感染实验和致病机制研究。此外,无菌动物作为关键工具,是研究菌群与疾病关系的核心,在微生物与宿主健康、疾病和感染机制研究过程中,起着不可替代的作用。本文将对无菌动物及其在微生物与宿主互作机制研究中的应用进行简要综述。     

建立我国规模化无菌动物高效研究应用体系

无菌动物与宏基因组技术是驱动人体健康微生物组研究的两大动力。没有无菌动物菌群(株)移植模型,就无法确立菌群与疾病的因果关系;没有无菌动物,就没有菌群与人体疾病研究飞速发展的今天与明天。无菌动物应用已形成有菌与无菌动物比较、菌群(株)移植、基因工程动物无菌化、无菌动物发育四种通用研究模式,研究模式的标准化将加大无菌动物研究应用规模及速度。本课题组经过十几年努力,已建成国内体量大、技术体系稳定、服务单位多、具有较大影响力的无菌动物平台,为国内生物医学、畜牧、食品微生物组科学问题解决提供了有力支撑。但是,目前我国无菌动物规模小、效率低、供用平台与应用条件分离,无菌动物基础理论与技术体系尚待发展,难以满足日益增长的应用需求。亟待建立规模化无菌动物高效研究应用体系,以适应我国微生物组研究高速发展。     

城市生活垃圾堆肥发酵中微生物菌群变化规律的研究

通过对垃圾处理厂静态堆肥不同区域的微生物菌群与数量的分析,表明了城市生活垃圾堆肥发酵中微生物菌群的变化规律,温度与微生物菌群的相关性,指出了高温微生物菌群数量影响堆肥的效率。建议在静态一次堆肥发酵周期中,增加通气量和翻堆频率,有利于增强微生物菌群的活力和提高堆肥质量。     

动物及其肠道菌群的协同进化研究

动物自身合成一些关键营养物质的能力缺失,转而依赖体内的共生物来完成相应功能,如动物体内共生细菌能帮助宿主从食物中提取营养物质,并能合成一些关键代谢反应的化合物。结合国内外在动物及其肠道菌群的协同进化的研究进展,从三个方面进行了归纳:(1)动物及其肠道微生物组成与功能的协同进化研究;(2)动物行为与肠道微生物的关系;(3)共生肠道微生物在人类或动物自身消化食物、营养获取、健康和疾病方面发挥的重要作用。     

植物病害防治相关微生物组研究进展与展望

微生物是人类活动过程中重要的生物资源。植物及其根围土壤中生存着大量多种多样的微生物,这些微生物与植物健康之间存在着密不可分的关系。近年来,基因测序技术的快速发展为植物微生物组结构和功能的研究提供了极大的便利,多种植物相关的微生物组得到了解析。同时更多研究者聚焦于植物病害相关的微生物组研究,通过差异分析,发现了一些特定的有益于植物健康的微生物菌群。此外,植物根围或根内微生物塑造的内在原理也得到了进一步的揭示。一系列植物微生物组研究为植物病害防治和新的微生物资源的挖掘提供了更多思路。     

基于机器学习的肠道菌群数据建模与分析研究综述

人体肠道菌群与人类的健康和疾病存在密切关系,对肠道菌群的宏基因组数据进行建模和分析,在疾病预测及诊断相关领域科学研究和社会应用方面均具有重要意义。本文从大数据分析和机器学习的角度,对人体肠道菌群数据的建模、分析和预测算法的原理、过程以及典型研究应用实例进行综述,以期推动肠道菌群分析相关研究发展以及探索结合机器学习算法进行肠道菌群分析的有效方式,同时也为开发基于肠道菌群数据的新型诊疗手段提供借鉴,推动我国精准医疗事业发展。     

Tumor Grafting Induces Changes of Gut Microbiota in Athymic Nude Mice in the Presence and Absence of Medicinal Gynostemma Saponins

Recent findings have revealed that gut microbiota plays a substantial role in modulating diseases such as autism, rheumatoid arthritis, allergies, and cancer that occur at sites distant to the gut. Athymic nude mice have been employed for tumorigenic research for decades; however, the relationships between the gut microbiome and host’s response in drug treatment to the grafted tumors have not been explored. In this study, we analyzed the fecal microbiome of nonxenograft and xenograft nude mice treated with phytosaponins from a popular medicinal plant, Gynostemma pentaphyllum (Gp). Analysis of enterobacterial repetitive intergenic consensus (ERIC)-PCR data showed that the microbiota profile of xenograft mice departed from that of the nonxenograft mice. After ten days of treatment with Gp saponins (GpS), the microbiota of the treated mice was closer to the microbiota at Day 0 before the implantation of the tumor. Data obtained from 16S pyrosequencing of fecal samples reiterates the differences in microbiome between the nonxenograft and xenograft mice. GpS markedly increased the relative abundance of Clostridium cocleatum and Bacteroides acidifaciens, for which the beneficial effects on the host have been well documented. This study, for the first time, characterizes the properties of gut microbiome in nude mice responding to tumor implant and drug treatment. We also demonstrate that dietary saponins such as GpS can potentially regulate the gut microbial ecosystem by increasing the number of symbionts. Interestingly, this regulation of the gut ecosystem might, at least in part, be responsible for or contribute to the anticancer effect of GpS.     

2016年动物胃肠道微生物组研究十大亮点成果

动物胃肠道微生物对生产性能提高具有重要的作用,因此营养、微生物组与生产表型的互作研究已经成为国际研究热点。综述了2016年动物胃肠道微生物组学研究取得的十项重要成果,这些成果通过组学方法,研究了瘤胃纤维分解菌和尿素分解菌的功能基因多样性,揭示了微生物群落与日粮营养素、宿主基因型、环境的互作关系,阐明了反刍动物生产表型相关的瘤胃微生物种类和功能;首次构建猪肠道微生物组参考基因集,解析猪全肠道黏膜微生物组成,阐明了猪增重相关肠道微生物种类。这十大亮点成果将为国内动物营养学家开展动物胃肠道微生物组学研究提供参考。     

The dynamic microbiome

While our genomes are essentially static, our microbiomes are inherently dynamic. The microbial communities we harbor in our bodies change throughout our lives due to many factors, including maturation during childhood, alterations in our diets, travel, illnesses, and medical treatments. Moreover, there is mounting evidence that our microbiomes change us, by promoting health through their beneficial actions or by increasing our susceptibility to diseases through a process termed dysbiosis. Recent technological advances are enabling unprecedentedly detailed studies of the dynamics of the microbiota in animal models and human populations. This review will highlight key areas of investigation in the field, including establishment of the microbiota during early childhood, temporal variability of the microbiome in healthy adults, responses of the microbiota to intentional perturbations such as antibiotics and dietary changes, and prospective analyses linking changes in the microbiota to host disease status. Given the importance of computational methods in the field, this review will also discuss issues and pitfalls in the analysis of microbiome time-series data, and explore several promising new directions for mathematical model and algorithm development.     

Dominant Effects of the Diet on the Microbiome and the Local and Systemic Immune Response in Mice

Outside the nutrition community the effects of diet on immune-mediated diseases and experimental outcomes have not been appreciated. Investigators that study immune-mediated diseases and/or the microbiome have overlooked the potential of diet to impact disease phenotype. We aimed to determine the effects of diet on the bacterial microbiota and immune-mediated diseases. Three different laboratory diets were fed to wild-type mice for 2 weeks and resulted in three distinct susceptibilities to dextran sodium sulfate (DSS)-induced colitis. Examination of the fecal microbiota demonstrated a diet-mediated effect on the bacteria found there. Broad-spectrum antibiotics disturbed the gut microbiome and partially eliminated the diet-mediated changes in DSS susceptibility. Dietary changes 2 days after DSS treatment were protective and suggested that the diet-mediated effect occurred quickly. There were no diet-mediated effects on DSS susceptibility in germ-free mice. In addition, the diet-mediated effects were evident in a gastrointestinal infection model (Citrobacter rodentium) and in experimental autoimmune encephalomyelitis. Taken together, our study demonstrates a dominant effect of diet on immune-mediated diseases that act rapidly by changing the microbiota. These findings highlight the potential of using dietary manipulation to control the microbiome and prevent/treat immune-mediated disease.     

Human microbiomics

The sequencing of the human genome has driven the study of human biology in a significant way and enabled the genome-wide study to elucidate the molecular basis of complex human diseases. Recently, the role of microbiota on human physiology and health has received much attention. The influence of gut microbiome (the collective genomes of the gut microbiota) in obesity has been demonstrated, which may pave the way for new prophylactic and therapeutic strategies such as bacteriotherapy. The significance and recent understandings in the area of “human microbiomics” are discussed here.     

Focus: Microbiome: Human Microbiota and Ophthalmic Disease

The human ocular surface, consisting of the cornea and conjunctiva, is colonized by an expansive, diverse microbial community. Molecular-based methods, such as 16S rRNA sequencing, has allowed for more comprehensive and precise identification of the species composition of the ocular surface microbiota compared to traditional culture-based methods. Evidence suggests that the normal microbiota plays a protective immunological role in preventing the proliferation of pathogenic species and thus, alterations in the homeostatic microbiome may be linked to ophthalmic pathologies. Further investigation of the ocular surface microbiome, as well as the microbiome of other areas of the body such as the oral mucosa and gut, and their role in the pathophysiology of diseases is a significant, emerging field of research, and may someday enable the development of novel probiotic approaches for the treatment and prevention of ophthalmic diseases.     

Imbalance of Gastrointestinal Microbiota in the Pathogenesis of Helicobacter pylori‐Associated Diseases

The development of new nucleotide sequencing techniques and advanced bioinformatics tools has opened the field for studying the diversity and complexity of the gastrointestinal microbiome independent of traditional cultural methods. Owing largely to the gastric acid barrier, the human stomach was long thought to be sterile. The discovery of Helicobacter pylori, the gram‐negative bacterium that infects upwards of 50% of the global population, has started a major paradigm shift in our understanding of the stomach as an ecologic niche for bacteria. Recent sequencing analysis of gastric microbiota showed that H. pylori was not alone and the interaction of H. pylori with those microorganisms might play a part in H. pylori‐associated diseases such as gastric cancer. In this review, we summarize the available literature about the changes of gastrointestinal microbiota after H. pylori infection in humans and animal models, and discuss the possible underlying mechanisms including the alterations of the gastric environment, the secretion of hormones and the degree of inflammatory response. In general, information regarding the composition and function of gastrointestinal microbiome is still in its infancy, future studies are needed to elucidate whether and to what extent H. pylori infection perturbs the established microbiota. It is assumed that clarifying the role of gastrointestinal communities in H. pylori‐associated diseases will provide an opportunity for translational application as a biomarker for the risk of serious H. pylori diseases and perhaps identify specific organisms for therapeutic eradication.     

Rapidly expanding knowledge on the role of the gut microbiome in health and disease

The human gut is colonized by a wide diversity of micro-organisms, which are now known to play a key role in the human host by regulating metabolic functions and immune homeostasis. Many studies have indicated that the genomes of our gut microbiota, known as the gut microbiome or our “other genome” could play an important role in immune-related, complex diseases, and growing evidence supports a causal role for gut microbiota in regulating predisposition to diseases. A comprehensive analysis of the human gut microbiome is thus important to unravel the exact mechanisms by which the gut microbiota are involved in health and disease. Recent advances in next-generation sequencing technology, along with the development of metagenomics and bioinformatics tools, have provided opportunities to characterize the microbial communities. Furthermore, studies using germ-free animals have shed light on how the gut microbiota are involved in autoimmunity. In this review we describe the different approaches used to characterize the human microbiome, review current knowledge about the gut microbiome, and discuss the role of gut microbiota in immune homeostasis and autoimmunity. Finally, we indicate how this knowledge could be used to improve human health by manipulating the gut microbiota. This article is part of a Special Issue entitled: From Genome to Function.